Whan In Pharm (016580.KS) Earnings Analysis

Whan In Pharm (016580.KS) has no confirmed upcoming earnings date. Trailing P/E 10.72.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 016580.KS next report earnings?

No confirmed upcoming earnings date is currently scheduled for 016580.KS. This page updates as the calendar is published.

016580.KS earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-27404 KRWn/an/an/a
2026-02-13108.16 KRWn/an/an/a
2025-04-30334.99 KRWn/an/an/a
2025-02-17234.77 KRWn/an/an/a
2024-11-01242.79 KRWn/an/an/a

016580.KS valuation and analyst view

Trailing P/E10.72
Trailing EPS857.05 KRW
Price / book0.43
Dividend yield3.03%
Market cap149.01B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Whan In Pharm (016580.KS)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 016580.KS. This page updates as the calendar is published.

Did 016580.KS beat earnings last quarter?

Consensus estimate data was not available for 016580.KS's 2026-04-27 report.

What is 016580.KS's current P/E ratio and EPS?

016580.KS trades at a trailing P/E of 10.72 on trailing EPS of 857.051735483871 KRW.

What do analysts rate 016580.KS?

016580.KS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.